An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria

Keyphrases

• Multidrug-resistant Gram-negative Bacteria 100%
• Ventilator-associated Pneumonia 100%
• Hospital-acquired 100%
• Community-acquired Pneumonia 75%
• Gram-negative Pathogens 75%
• MDR Gram-negative 75%
• Risk Factors 50%
• Pneumonia Ventilator-associated 50%
• Nosocomial Pneumonia 50%
• MDR Bacteria 50%
• MDR Pathogens 50%
• Delayed Diagnosis 25%
• Patient Characteristics 25%
• Increasing Prevalence 25%
• Hospitalization 25%
• Hospital Setting 25%
• Antimicrobial Therapy 25%
• Multidrug-resistant Pathogens 25%
• Therapeutic Potential 25%
• Current Guidelines 25%
• Admission to Hospital 25%
• Microbiological Data 25%
• Global Threats 25%
• Local Ecology 25%
• Pathogen Management 25%
• Poor Clinical Outcomes 25%
• Septic Shock 25%
• Broad-spectrum Antibiotics 25%
• International Guidelines 25%

Medicine and Dentistry

• Pathogen 100%
• Multidrug-Resistant Gram-Negative Bacteria 100%
• Ventilator-Associated Pneumonia 100%
• Hospital-Acquired Pneumonia 42%
• Prevalence 14%
• Clinician 14%
• Awareness 14%
• Antimicrobial Therapy 14%
• Gram-Negative Bacteria 14%
• Broad-Spectrum Antibiotic 14%
• Septic Shock 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Infectious Agent 100%
• Ventilator Associated Pneumonia 100%
• Multidrug-Resistant Gram-Negative Bacteria 100%
• Hospital Acquired Pneumonia 42%
• Prevalence 14%
• Antibiotics 14%
• Antimicrobial Therapy 14%
• Septic Shock 14%
• Gram Negative Bacterium 14%